雜志介紹

Congenital Heart Disease雜志介紹

《Congenital Heart Disease》是一本(ben)(ben)以(yi)(yi)English為主的(de)(de)開放獲取(qu)國際優秀期(qi)刊(kan)，中文名稱先天性心臟病(bing)，本(ben)(ben)刊(kan)主要出版、報道醫學(xue)(xue)(xue)-CARDIAC & CARDIOVASCULAR SYSTEMS領(ling)域(yu)的(de)(de)研究動(dong)(dong)態以(yi)(yi)及(ji)在該(gai)(gai)領(ling)域(yu)取(qu)得(de)的(de)(de)各方(fang)面(mian)的(de)(de)經(jing)驗和科研成果，介紹該(gai)(gai)領(ling)域(yu)有關本(ben)(ben)專(zhuan)業的(de)(de)最(zui)新(xin)(xin)進展，探(tan)討行(xing)業發展的(de)(de)思路和方(fang)法(fa)，以(yi)(yi)促進學(xue)(xue)(xue)術(shu)信(xin)息交流，提高行(xing)業發展。該(gai)(gai)刊(kan)已(yi)被(bei)國際權威數(shu)(shu)據庫SCIE收錄，為該(gai)(gai)領(ling)域(yu)相關學(xue)(xue)(xue)科的(de)(de)發展起(qi)到了良(liang)好的(de)(de)推(tui)動(dong)(dong)作用，也得(de)到了本(ben)(ben)專(zhuan)業人員的(de)(de)廣泛認可(ke)。該(gai)(gai)刊(kan)最(zui)新(xin)(xin)影響因子為0.3，最(zui)新(xin)(xin)CiteScore 指數(shu)(shu)為0.4。

本(ben)刊近期(qi)中國(guo)學者發(fa)表的(de)論文主要(yao)有：

• Strategy of treating secundum atrial septal defect not referred to percutaneous closure.

  Author: Zhang F¹, Yang Y², Wu Q², Jin W², Bu H², Wu S², Zhao T², Hu S².

• Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model.

  Author: Chen X¹, Zhou W¹, Hu Q¹, Huang L¹.

• Percutaneous Closure of Perimembranous Ventricular Septal Defect with Modified Double-disk Occluder: What Is the Outcome at 10-year Follow-up?

  Author: Bai Y, Liu J, Qin YW, Wu H, Zhao XX.

• Clinical Experience of Transcatheter Closure for Residual Ventricular Septal Defect in Pediatric Patients.

  Author: Zhou W, Li F, Fu L, Gao W, Guo Y, Liu T, Huang M, Zhang Y.

英文介紹

Congenital Heart Disease雜志英文介紹

Congenital Heart Disease is an open-access journal focusing on congenital heart disease in children and adults. Though the number of infants born with heart disease each year is relatively small (approximately 1% of the population), advances in treating such malformations have led to increased life spans for this population. Consequently, today most patients treated for congenital heart disease are over the age of 20. What are the special needs of adults with congenital heart disease? What are the latest developments in the care of the fetus, infants, and children? Who should treat these patients? How should they be treated?

Congenital Heart Disease focuses on these questions and more. Conceived as a forum for the most up-to-date information on congenital heart disease, the journal is led by Editor-in-Chief Vladimiro L. Vida, MD, Ph.D., Professor in Cardiac Surgery, University of Padua in Italy, as well as an international editorial board. Congenital Heart Disease publishes articles on heart disease as it relates to the following areas:

? Basic research of congenital heart disease

? Clinical pediatric and adult cardiology

? Cardiac imaging

? Preventive cardiology

? Diagnostic and interventional cardiac catheterization

? Electrophysiology

? Surgery

? Long-term follow-up, particularly as it relates to older children and adult congenital heart disease

? Exercise and exercise physiology in the congenital patient

? Post-op and critical care

? Common disorders such as syncope, chest pain, murmurs, as well as acquired disorders such as Kawasaki syndrome

The journal includes clinical studies, invited editorials, state-of-the-art reviews, case reports, articles focusing on the history and development of congenital heart disease, and CME material. Occasional issues focus on special topics.

Readership: Congenital Heart Disease was created for pediatric cardiologists; adult cardiologists who care for patients with congenital heart disease; pediatric and pediatric cardiology nurses; surgeons; radiologists; anesthesiologists; critical care physicians and nurses; and adult support staff involved in the care of patients with congenital heart disease.